Clinical Trial Update: TDM of Generic Lopinavir/Ritonavir 200/50 mg [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on therapeutic drug monitoring (TDM) of generic lopinavir/ritonavir 200/50 mg for HIV treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• lopinavir/ritonavir 200/50 mg (generic) (lopinavir/ritonavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV | Phase 2 | Status: COMPLETED